Craig Elliot White

Craig Elliot White is an accomplished professional with extensive experience in the biopharmaceutical industry, primarily focusing on rare diseases and key account management. Currently serving as the Sr National Key Account Manager for BioCryst Pharmaceuticals, Inc., Craig is responsible for the commercial launch of the first oral treatment for Hereditary Angioedema in the UK and Ireland. Previous roles include National Key Account Manager positions at Sobi and Akcea Therapeutics, where Craig successfully managed strategic initiatives for ultra orphan diseases. With a strong background in training and project management from Alnylam Pharmaceuticals and Biogen, Craig has demonstrated a consistent ability to drive sales growth and build effective relationships across healthcare sectors. Academic credentials include a BA (Hons) in Psychology from the University of Liverpool and certifications in training and project management.